Rinvoq (upadacitinib)

pCPA File Number: 21190

Negotiation Status:

Under consideration for negotiation

Indication(s):

Subacute and chronic inflammatory joint diseases

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

SR0614-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable